Skip to content
Update on Marginal Zone Lymphoma (MZL) episode artwork

Jun 23, 2021 1 hr 7 min

Update on Marginal Zone Lymphoma (MZL)

from Marginal Zone Lymphoma CancerCare Connect Education Workshops

- Overview of Marginal Zone Lymphoma (MZL), including Staging and Location, in the Context of COVID-19 - Subtypes of Marginal Zone Lymphoma - Review of Treatment Options - Treatment for Relapsed/Refractory Marginal Zone Lymphoma - Managing Treatment Side Effects, Symptoms & Discomfort - Key Questions to Ask Your Health Care Team - The Important Role of Clinical Trials, in the Context of COVID-19 - How Research Contributes to Your Treatment Options - The Increasing Role of Telehealth/Telemedicine Appointments - Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & Prepared List of Questions - Quality-of-Life Concerns & Follow-Up Care - Questions for Our Panel of Experts

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Update on Marginal Zone Lymphoma (MZL)

0:00 1:07:43

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Marginal Zone Lymphoma CancerCare Connect Education Workshops?

This episode is 1 hour and 7 minutes long.

When was this Marginal Zone Lymphoma CancerCare Connect Education Workshops episode published?

This episode was published on June 23, 2021.

Can I download this Marginal Zone Lymphoma CancerCare Connect Education Workshops episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.